Showing results (161-170 of 193) with videos related to

Sort By:
Pageof 20
Swiss Medical Weekly|July 9, 2024
Real-life experience of chronic hepatitis C treatment in Switzerland: a retrospective analysisEleni Moschouri, Gloria Salemme, Adriana Baserga, et al.
Hepatology (Baltimore, Md.)|October 31, 2015
DEPDC5 variants increase fibrosis progression in Europeans with chronic hepatitis C virus infectionMaria Antonella Burza, Benedetta Maria Motta, Rosellina Margherita Mancina, et al.
Inflammatory Bowel Diseases|July 28, 2021
New Therapeutic Approach for Intestinal Fibrosis Through Inhibition of pH-Sensing Receptor GPR4Bruce Weder, Fabian Schefer, Wouter Tobias van Haaften, et al.
Experimental and Molecular Pathology|February 22, 2022
Alcohol: basic and translational research; 15th annual Charles Lieber &1st Samuel French satellite symposiumManuela G Neuman, Helmut K Seitz, Pamela L Tuma, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|January 10, 2019
Predniso(lo)ne Dosage and Chance of Remission in Patients With Autoimmune HepatitisSimon Pape, Tom J G Gevers, Michail Belias, et al.
Hepatology International|June 2, 2021
Combined effects of PNPLA3, TM6SF2 and HSD17B13 variants on severity of biopsy-proven non-alcoholic fatty liver diseaseRafael Paternostro, Katharina Staufer, Stefan Traussnigg, et al.
Nature Communications|October 10, 2018
Epigenomic map of human liver reveals principles of zonated morphogenic and metabolic controlMario Brosch, Kathrin Kattler, Alexander Herrmann, et al.
Plos One|January 26, 2012
A common variant of PNPLA3 (p.I148M) is not associated with alcoholic chronic pancreatitisJonas Rosendahl, Anke Tönjes, Dorit Schleinitz, et al.
Pageof 20